Navigation Links
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
Date:5/8/2008

DEERFIELD, Ill., May 8 /PRNewswire-FirstCall/ -- Siemens Healthcare and Laboratory Corporation of America(R) Holdings (LabCorp(R)) today announced that they have entered a non-exclusive agreement to discuss future possibilities to co-develop new clinical diagnostic tests in the areas of companion diagnostics, metabolic syndrome, oncology and diabetes. Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO )

Companion diagnostics are tests designed to identify the suitability between patients and a particular drug therapy. The tests can be used in personalized medicine to improve safety and efficacy of therapeutic drugs and in some cases, may help determine optimal dosing for individual patients. Metabolic syndrome is becoming more common and is characterized by a person having multiple risk factors that may include high blood pressure, heart disease, obesity and diabetes, among others. It's estimated that more than 50 million people are affected by this syndrome in the United States alone(1).

Diabetes is a chronic disease currently affecting more than 180 million people worldwide and is likely to more than double by 2030(2). Early detection and treatment of diabetes may enable a patient to better maintain their lifestyle. In addition, the possibility of advancing early detection of cancer is important as it may lead to higher survival rates. One in eight deaths worldwide is due to cancer, and in 2007, there were more than 12 million estimated new cancer cases worldwide(3).

Siemens is a leader in the diagnostic industry with the broadest range of products and services used for diagnosing medical conditions and monitoring patient therapy; LabCorp is a reference laboratory successfully serving more than 220,000 clien
'/>"/>

SOURCE Siemens Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
2. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
3. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
4. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
5. Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing
6. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
7. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
10. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
11. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced ... 9 th Annual Global Pharma Manufacturing Summit ... 8-9 th . The Global Pharma Manufacturing Summit ... small molecule and biologic pharmaceutical manufacturing. The conference ... today,s manufacturers face, such as the increasing pressure ...
(Date:8/28/2014)... , Aug. 28, 2014  Robotic surgery is ... media, both for the promise of improved outcomes ... quick deployment of surgical robots and market pressures ... facilities to evaluate their robotic surgery training programs ... team.    ECRI Institute ( www.ecri.org ...
(Date:8/28/2014)... THOUSAND OAKS, Calif. , Aug. 28, 2014 /PRNewswire/ ... the submission of a Biologics License Application (BLA) to ... seeking approval for the treatment of high cholesterol. Evolocumab ... proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that ... (LDL-C), or "bad" cholesterol, from the blood. 1 ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 2Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 3Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 4Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 5Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 6Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 7Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 8Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA 9
... Mass. , July 26 The Exergen ... nationwide that stock the Exergen TemporalScanner™, according to data ... of all types of thermometers, including national brands and ... found Exergen came out on top. Exergen,s retail unit ...
... , NEWARK, Del. and GRONINGEN, Netherlands ... a leading full-service GLP/GCP-compliant contract research organization providing testing ... announced the completion of its acquisition of Xendo Drug ... .  XDD, a European contract research organization (CRO), will ...
Cached Medicine Technology:Exergen TemporalScanner Thermometer Best Selling Brand at Retailers 2QPS Announces the Acquisition of Xendo Drug Development 2QPS Announces the Acquisition of Xendo Drug Development 3QPS Announces the Acquisition of Xendo Drug Development 4
(Date:8/28/2014)... Mateo, CA (PRWEB) August 28, 2014 ... that the MRI Technology program is re-accredited for the ... of Magnetic Resonance Imaging Technologists (ARMRIT). , “We ... We are constantly improving our program to make sure ... is a lot of interest in MRI field nowadays ...
(Date:8/28/2014)... Did they fall from trees and learn to flap their ... ground and pump their "arms" to get aloft? , The ... a new University of California, Berkeley, study provides a new ... maneuver in midair, a talent that could have helped their ... , The study looked at how baby birds, in this ...
(Date:8/28/2014)... Data from the American Hospital Association’s 2013 Annual ... a basic electronic health record (EHR) system, more advanced ... challenge. , This data is featured in an ... , and is co-authored by Peter Kralovec, executive director ... as Chantal Worzala, director for policy at the AHA. ...
(Date:8/28/2014)... Ariz. Aug. 28, 2014 In 2012, ... million in grants for two groundbreaking brain cancer ... (TGen). One of those projects has officially received ... San Francisco, which means patient enrollment for the ... project, "Genomics Enabled Medicine in Glioblastoma Trial," TGen ...
(Date:8/28/2014)... CORAL GABLES, Fla (Aug. 26, 2014)-- Cigarette smoking ... the Centers for Disease Control and Protection. It,s ... order to overcome this addiction, many people resort ... literature review study by researchers at the University ... nicotine found in cigarette substitutes could be harmful ...
Breaking Medicine News(10 mins):Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2Health News:Flapping baby birds give clues to origin of flight 2Health News:Flapping baby birds give clues to origin of flight 3Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3Health News:TGen receives approval for patient enrollment in brain cancer clinical trial 2Health News:Are cigarette substitutes a safe alternative? It depends on user habits 2Health News:Are cigarette substitutes a safe alternative? It depends on user habits 3
... In a research paper presented at the 113th Annual ... that it is possible to regulate the incidence of ... the computer to stay connected with people.,The data regarding ... of the latest wave of an ongoing longitudinal study ...
... was extracted from the Herb Black Cohosh [An Indian herb], ... [HRT]. Doctors say herb used by American Indians for ... for women going through menopause. As synthetic HRT use is ... , ,Professor John Eden from Sydney’s Royal Hospital for ...
... hours for treatment for heart attacks, may be more ... blood flow, said a research // findings in the ... blood flow to an organ or tissue) with either ... coronary intervention (PCI; procedures such as angioplasty in which ...
... how neurons fire in a part of the brain ... of schizophrenia and Alzheimer's disease. // , ,A ... nervous system has been the focus of the research. ... them where they're supposed to go. In adult mice, ...
... disorders like rheumatoid arthritis may be reduced by ... carrots and sweetcorn. //, ,Vitamin C and ... in brightly-coloured fruit and veg, may act as ... damage and inflammation. ,The levels of intake ...
... Researchers from University of Michigan had identified a protein ... sensori-neural hearing loss or AISNHL.//, ,In the August ... Neck Surgery, researchers reports results from a study of ... Pennsylvania and Indiana, and 20 people with normal hearing. ...
Cached Medicine News:Health News:Heart Attack Patients Reaching Hospital During Off-Hours Have Increased Risk Of Death 2Health News:Learning process to be regulated by altering brain protein 2
... Introducing the new PRONEB® ULTRA compressor. ... treatment time while delivering more medication to ... PARI LC PLUS® or PARI LC STAR® ... are optimized for inhalation and retention into ...
... Compressed Air., ,Allied Healthcares Timeter® PCS 414 ... other air compressors that you may wonder if ... PCS 414 features a durable, mar-resistant steel case ... unit weighs only 26.5 pounds. The PCS 414 ...
... DC powered compressor nebulizer system available. ... to take nebulizer treatments away from ... the included AC power adapter or ... The integral reusable jet nebulizer kit ...
The 45 PSI SuperSportNeb provides superior performance that translates to shorter treatment times. Like the SportNeb, it is constructed with die-cast aluminum compressor components for consistent rel...
Medicine Products: